AIM ImmunoTech Inc. AIM
$0.25
+12.05%
at last close
Analyst Consensus
- Consensus Rating
- Buy (1 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $9.00
- Implied Upside
- +3552.6%
- Price Target Range
- $9.00 – $9.00
- Analysts (12 mo)
- 1
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-06-01 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $10 → $9 |
| 2026-04-10 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $22 → $10 |
| 2025-12-08 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $24 → $22 |
| 2025-10-03 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $150 → $24 |
| 2024-12-10 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $5 → $5 |
| 2024-10-22 | Maxim GroupJason McCarthy |
Maintains | Buy | $2 → $1 |
| 2024-09-03 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $5 → $5 |
| 2019-10-10 | Maxim Group |
Upgrades | Hold → Buy | — |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $0.25
- Market Cap
- $6.69 million
- 52-Week Range
- $0.19 – $20.33
- Average Volume
- 1.18 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.